Background image

News & Events

October 12, 2023

Raising awareness of secondary breast cancer

Shawna Koch Mishael
Shawna Koch Mishael
Vice President, Healthcare Business
Quantori

October is International Breast Cancer Awareness Month, focusing this year on raising awareness of secondary breast cancer, where the disease spreads to other parts of the body. Modern developments and solutions in the healthcare domain are aimed at early detection of this type of cancer and providing evolving and innovative treatment that’s taking place to relieve symptoms and maintain quality of life to achieve a positive prognosis of secondary breast cancer.

Quantori is at the forefront of innovation in the life sciences and healthcare industries, including helping companies with earlier cancer diagnostics. Learn more about what we do.

What are the trends in cancer diagnostics and treatment, and what must be done to gain success in fighting this disease? Shawna Koch Mishael, Global Head of Healthcare at Quantori, shares her vision:

In recent years, significant genomic advances have revolutionized breast cancer detection, and we at Quantori are excited to be at the forefront of that work with our customers worldwide. Through the decoding of genetic markers and the understanding of molecular subtypes, early and more accurate detection of breast cancer has become possible, offering tailored treatment pathways for patients.

However, these advancements are only as effective as the regularity with which they’re employed. It’s imperative for healthcare providers, with the support of payers, to emphasize the importance of routine diagnostics through cloud-based tools that analyze patient history to alert clinicians and caregivers of timely diagnostic and appointment needs. Hospitals must actively engage with their communities, campaigning for regular screenings and follow-ups. It’s more than just an appointment — it’s a proactive commitment to health.

By fostering an environment where patients are consistently prompted and encouraged both in person and through technological tools to be actively involved in their health journeys, we can truly harness the power of these genomic breakthroughs, translating them into improved patient outcomes and saved lives.